Hypercholesterolaemia-induced oxidative stress at the blood-brain barrier

Irundika H.K. Dias, Maria C. Polidori, Helen R. Griffiths

Research output: Contribution to journalArticle

Abstract

Blood cholesterol levels are not consistently elevated in subjectswith age-related cognitive decline, although epidemiological studies suggest that Alzheimer's disease and cardiovascular diseases share common risk factors. These include the presence of an unusual genetic variant, the APOE4 (apolipoprotein E4) allele, which modulates LDL (low-density lipoproteins) metabolism, increases free radical formation and reduces plasma antioxidant concentrations. Together, these risk factors support a mechanism for increased LDL circulation time and free radical modification of LDL. Plasma oxycholesterols, hydroxylated metabolites of cholesterol, are carried by oxidized LDL, and elevated lipids in mid-life are associated with increased longterm risk of dementia. Although brain cholesterol metabolism is segregated from the systemic circulation, during oxidative stress, plasma oxycholesterols could have damaging effects on BBB (blood-brain barrier) function and consequently on neuronal cells. Cholesterol-lowering drugs such as statins may prevent the modifications to LDL in mid-life and might show beneficial effects in later life. © The Authors Journal compilation © 2014 Biochemical Society.

LanguageEnglish
Pages1001-1005
Number of pages5
JournalBiochemical Society Transactions
Volume42
Issue number4
DOIs
Publication statusPublished - Aug 2014

Fingerprint

Oxidative stress
Hypercholesterolemia
Blood-Brain Barrier
LDL Lipoproteins
Oxidative Stress
Cholesterol
Plasmas
Metabolism
Free Radicals
Apolipoprotein E4
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Metabolites
Dementia
Epidemiologic Studies
Brain
Alzheimer Disease
Blood
Cardiovascular Diseases
Antioxidants
Alleles

Bibliographical note

© the Biochemical Society.

Provided the original publication of the article, or portion of the article, is properly cited, Authors retain the following non-exclusive rights:

1.To reproduce their article in whole or in part in any printed volume (book or thesis) of which they are the Author or Editor
2.To reproduce their article in whole or in part at the Author's current academic institution for teaching purposes
3.To reuse figures, tables, illustrations or photos from the article in commercial or non-commercial works created by them
4.To post a copy of the Immediate Publication (i.e. the Accepted Manuscript*) at the Author's Institutional Repository, 6 months after publication, provided that this is linked to the article on the journal website (e.g. through the DOI).

Keywords

  • alzheimer's disease
  • blood-brain barrier
  • liver X receptor (LXR)
  • low-density lipoprotein (LDL)
  • oxidative stress
  • oxysterol
  • statin

Cite this

Dias, Irundika H.K. ; Polidori, Maria C. ; Griffiths, Helen R. / Hypercholesterolaemia-induced oxidative stress at the blood-brain barrier. In: Biochemical Society Transactions. 2014 ; Vol. 42, No. 4. pp. 1001-1005.
@article{09324a641fe94481b183dbd7a485b344,
title = "Hypercholesterolaemia-induced oxidative stress at the blood-brain barrier",
abstract = "Blood cholesterol levels are not consistently elevated in subjectswith age-related cognitive decline, although epidemiological studies suggest that Alzheimer's disease and cardiovascular diseases share common risk factors. These include the presence of an unusual genetic variant, the APOE4 (apolipoprotein E4) allele, which modulates LDL (low-density lipoproteins) metabolism, increases free radical formation and reduces plasma antioxidant concentrations. Together, these risk factors support a mechanism for increased LDL circulation time and free radical modification of LDL. Plasma oxycholesterols, hydroxylated metabolites of cholesterol, are carried by oxidized LDL, and elevated lipids in mid-life are associated with increased longterm risk of dementia. Although brain cholesterol metabolism is segregated from the systemic circulation, during oxidative stress, plasma oxycholesterols could have damaging effects on BBB (blood-brain barrier) function and consequently on neuronal cells. Cholesterol-lowering drugs such as statins may prevent the modifications to LDL in mid-life and might show beneficial effects in later life. {\circledC} The Authors Journal compilation {\circledC} 2014 Biochemical Society.",
keywords = "alzheimer's disease, blood-brain barrier, liver X receptor (LXR), low-density lipoprotein (LDL), oxidative stress, oxysterol, statin",
author = "Dias, {Irundika H.K.} and Polidori, {Maria C.} and Griffiths, {Helen R.}",
note = "{\circledC} the Biochemical Society. Provided the original publication of the article, or portion of the article, is properly cited, Authors retain the following non-exclusive rights: 1.To reproduce their article in whole or in part in any printed volume (book or thesis) of which they are the Author or Editor 2.To reproduce their article in whole or in part at the Author's current academic institution for teaching purposes 3.To reuse figures, tables, illustrations or photos from the article in commercial or non-commercial works created by them 4.To post a copy of the Immediate Publication (i.e. the Accepted Manuscript*) at the Author's Institutional Repository, 6 months after publication, provided that this is linked to the article on the journal website (e.g. through the DOI).",
year = "2014",
month = "8",
doi = "10.1042/BST20140164",
language = "English",
volume = "42",
pages = "1001--1005",
journal = "Biochemical Society Transactions",
issn = "0300-5127",
publisher = "Portland Press Ltd.",
number = "4",

}

Hypercholesterolaemia-induced oxidative stress at the blood-brain barrier. / Dias, Irundika H.K.; Polidori, Maria C.; Griffiths, Helen R.

In: Biochemical Society Transactions, Vol. 42, No. 4, 08.2014, p. 1001-1005.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hypercholesterolaemia-induced oxidative stress at the blood-brain barrier

AU - Dias, Irundika H.K.

AU - Polidori, Maria C.

AU - Griffiths, Helen R.

N1 - © the Biochemical Society. Provided the original publication of the article, or portion of the article, is properly cited, Authors retain the following non-exclusive rights: 1.To reproduce their article in whole or in part in any printed volume (book or thesis) of which they are the Author or Editor 2.To reproduce their article in whole or in part at the Author's current academic institution for teaching purposes 3.To reuse figures, tables, illustrations or photos from the article in commercial or non-commercial works created by them 4.To post a copy of the Immediate Publication (i.e. the Accepted Manuscript*) at the Author's Institutional Repository, 6 months after publication, provided that this is linked to the article on the journal website (e.g. through the DOI).

PY - 2014/8

Y1 - 2014/8

N2 - Blood cholesterol levels are not consistently elevated in subjectswith age-related cognitive decline, although epidemiological studies suggest that Alzheimer's disease and cardiovascular diseases share common risk factors. These include the presence of an unusual genetic variant, the APOE4 (apolipoprotein E4) allele, which modulates LDL (low-density lipoproteins) metabolism, increases free radical formation and reduces plasma antioxidant concentrations. Together, these risk factors support a mechanism for increased LDL circulation time and free radical modification of LDL. Plasma oxycholesterols, hydroxylated metabolites of cholesterol, are carried by oxidized LDL, and elevated lipids in mid-life are associated with increased longterm risk of dementia. Although brain cholesterol metabolism is segregated from the systemic circulation, during oxidative stress, plasma oxycholesterols could have damaging effects on BBB (blood-brain barrier) function and consequently on neuronal cells. Cholesterol-lowering drugs such as statins may prevent the modifications to LDL in mid-life and might show beneficial effects in later life. © The Authors Journal compilation © 2014 Biochemical Society.

AB - Blood cholesterol levels are not consistently elevated in subjectswith age-related cognitive decline, although epidemiological studies suggest that Alzheimer's disease and cardiovascular diseases share common risk factors. These include the presence of an unusual genetic variant, the APOE4 (apolipoprotein E4) allele, which modulates LDL (low-density lipoproteins) metabolism, increases free radical formation and reduces plasma antioxidant concentrations. Together, these risk factors support a mechanism for increased LDL circulation time and free radical modification of LDL. Plasma oxycholesterols, hydroxylated metabolites of cholesterol, are carried by oxidized LDL, and elevated lipids in mid-life are associated with increased longterm risk of dementia. Although brain cholesterol metabolism is segregated from the systemic circulation, during oxidative stress, plasma oxycholesterols could have damaging effects on BBB (blood-brain barrier) function and consequently on neuronal cells. Cholesterol-lowering drugs such as statins may prevent the modifications to LDL in mid-life and might show beneficial effects in later life. © The Authors Journal compilation © 2014 Biochemical Society.

KW - alzheimer's disease

KW - blood-brain barrier

KW - liver X receptor (LXR)

KW - low-density lipoprotein (LDL)

KW - oxidative stress

KW - oxysterol

KW - statin

UR - http://www.scopus.com/inward/record.url?scp=84905867898&partnerID=8YFLogxK

U2 - 10.1042/BST20140164

DO - 10.1042/BST20140164

M3 - Article

VL - 42

SP - 1001

EP - 1005

JO - Biochemical Society Transactions

T2 - Biochemical Society Transactions

JF - Biochemical Society Transactions

SN - 0300-5127

IS - 4

ER -